DOCSLIB.ORG

Product Identification Number (PIN) List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product Identification Number (PIN) List Product Identification Number (PIN) List PIN Name 77154176 2-Deoxy-D-Glucose 79000015 Acacia Powder, NF Spray Dried 77700469 Acetaminophen powder 77764197 Acetic Acid, USP 77767641 Acetone Liquid 71071734 Acetyl Alcohol Liquid 77750782 Acetyl Salicylic Acid, USP 77616911 Acetylcysteine, USP 77512176 Acetyl-D-Glucosamine 75080502 Acetyl-L-Carnitine Hydrochloride 78048520 Acriflavine (Neutral Powder) 77440440 Activated Charcoal, USP 59277893 Acyclovir, USP 77761198 Adenosine-5 Monophosphate 79002602 Adrenocorticotrophic Hormone (ACTH) 77700174 AeroChamber/Spacers (All Brands/Types) 77700427 Aerosol Compressor (All Brands/Types) 77700529 Albuterol Sulphate Powder 977064 Alcohol Swabs (All Brands/Types) 79005383 Alginate Sodium Powder 77797596 Allantoin, USP 966134 Allergy Serums (All Brands/Types) 77700001 Aloe Vera Powder - Freeze Dried 77328507 Alpha-Ketoglutaric Acid 77745653 Alprostadil, USP 77784136 Aluminum Cl Powder, USP Product Identification Number (PIN) List 77446700 Aluminum Cl Powder, USP (anhydrous) 901997 Amidon Powder 77760322 Aminocaproic Acid, USP 77700521 Aminophylline Powder 77549188 Amitriptyline Hydrochloride, USP 78000735 Ammonium Carbonate, NF 71397893 Amphotericin B, USP (Oral Grade) 77700036 Anhydrous Eucerin 71143380 Anthralin 92099969 Antibiotic adherence (follow-up) 92099968 Antibiotic adherence (Initial) 41372207 Apomorphine Hydrochloride,USP 77700472 Applicator (All Brands/Types/Sizes) Anurex/Silver Nitrate 71119342 Arginine Hydrochloride,USP 77774793 Arginine, USP 77750817 Ascorbic Acid, USP 77700526 Ascorbyl Palmitate powder 29122687 Atenolol, USP 77751558 Atropine Sulfate Powder 77446866 Azathioprine, USP 77123999 Azelaic Acid (Flakes) 77700084 Azithromycin, USP (Dihydrate) 77700242 Baby Formula Liquid (All Brands/Types) 77700241 Baby Formula Powder (All Brands/Types) Enfamil/Isomil/Similac 77700101 Baby Supplies Wipes/Diapers/Oil/Powder (All Brands/Types) 77145896 Bacitracin Zinc, USP (Micronized) 71134470 Baclofen, USP Product Identification Number (PIN) List 77700437 Bandages/Dressings/Gauze/Tape (All Brands/Types) 77767527 Barbituric Acid 78012893 Beeswax 77700259 Benzocaine powder 77765850 Benzoic Acid 77700484 Benzoyl Peroxide 70% (All Brands/All Types) 77107437 Betaine (Anhydrous) 75593204 Betamethasone Dipropionate,USP 72152445 Betamethasone Valerate, USP (Micronized) 77700037 Biobase (All Types) 77758855 Biotin, USP 900346 Bismuth Gallate Powder 75892104 Bismuth Subcarbonate, USP 77799263 Bismuth Subgallate, USP 71304854 Bismuth Subnitrate, USP 77700210 Blood Pressure Monitor (All) 77700002 Bonney's Blue Solution 10043353 Boric Acid, NF (Powder) 77700222 Brace/Support (All Brands/Types/Sizes) 77700397 Brewers Yeast 500mg 77700505 Brimonidine Tartrate Powder 51333223 Budesonide, BP (Micronized) 14252803 Bupivacaine Hydrochloride,USP 53152219 Buprenorphine Hydrochloride, USP 77777269 Butalbital, USP 77771363 Butyl Alcohol, NF 77128370 Butylated Hydroxytoluene, NF (BHT) Product Identification Number (PIN) List 77758082 Caffeine, USP Anhydrous 77700355 Calamine Powder 77700257 Calcium - Oyster Shell 75743271 Calcium Ascorbate, USP 77471341 Calcium Carbonate, USP (Precipitated) 10035048 Calcium Chloride, USP (Dihydrate) 75785444 Calcium Citrate, USP 77299285 Calcium Gluconate, USP (Anhydrous) 71305620 Calcium Hydroxide, USP 77137086 Calcium Pantothenate, USP 77776222 Camphor, USP (Synthetic Crystals) 77404864 Capsaicin (95%) 77700515 Carbamazepine powder 77769818 Carbazochrome 77700476 Carbomer 940 NF 30301111 Cardiovascular Risk Assessment 30302222 Cardiovascular Risk Assessment (CVRA) Clinical Trial 77778444 Carisoprodol, USP 77541151 Carnitine (L) 77700094 Catheter (All Brands/Types/Sizes) 77700038 Cellulose, NF 79004346 Cellulose, NF (Microcrystalline) 36653824 Cetyl Alcohol, NF 77700465 Cetylpyridinium Chloride USP 77474259 Chenofalk Capsules 77756757 Chloramphenicol, USP 18472510 Chlorhexidine Gluconate 20% Solution, BP Product Identification Number (PIN) List 77767663 Chloroform, ACS 11041126 Cholestyramine Resin, USP 14639259 Chromium Picolinate 77480400 Chrysin 41621492 Ciclopirox Olamine, USP 51481619 Cimetidine, USP 86393320 Ciprofloxacin Hydrochloride, USP 81098604 Cisapride, EP 77700504 CitraFlow 4% Syringe 77777929 Citric Acid, USP (Anhydrous) 75949291 Citric Acid, USP (Monohydrate) 77700480 Citronella Oil 77372758 Citrulline (L) 77700284 Cleanser (All Brands/Types) Bar/Liquid/Soap/Scrub/Wash 21462395 Clindamycin HCL Powder, USP 24729962 Clindamycin Phosphate, USP 25122467 Clobetasol 17-Propionate,USP (Micronized) 17321776 Clomipramine Hydrochloride, USP 74205918 Clonidine Hydrochloride, USP 23593751 Clotrimazole, USP 77700004 Coal Tar, USP 77700390 Cocaine Powder 77700206 Codeine Phosphate Powder 78068288 Colistimethate Sodium, USP 79001121 Collagenase (Clostridiopeptidase A) 77700347 Compression Stockings/Socks/Support Hose/Insoles (All Brands/Types/Sizes) 77700105 Condoms/Spermicidal/Lubricant (All Brands/Types) K Y Jelly/Muko Product Identification Number (PIN) List 77700244 Contact Lens Solution (All Brands/Types) 77758998 Copper Sulfate (Technical) 79005258 Corn Starch 77700514 Cotton balls (all brands) 77700448 Cream (All Brands/Types) Base 76020877 Creatine (Monohydrate) 15826376 Cromolyn Sodium, USP 77700533 Cupric Oxide Powder 77768199 Cyanocobalamin, USP 76202239 Cyclobenzaprine Hydrochloride, USP 59865133 Cyclosporine A, USP 77969335 Cyproheptadine HCl, USP 77760231 Cystagon Capsule 27761199 Cysteamine Bitartrate 24868200 Dantrolene Sodium, USP 77780080 Dapsone, USP 900923 Debrisan Packet 77753430 Dehydroepiandrosterone (Micronized) 77700444 Deodorant (All Brands/Types) 77700496 Depokate Sprinkle Caps 125mg 77638948 Desonide Powder 77750022 Dexamethasone, USP 77781130 Dexpanthenol, USP 76700341 Dextromethorphan Hydrobromide,USP 77750997 Dextrose, USP Anhydrous 75996101 Dextrose, USP Monohydrate 77700208 Diabetes/Diabetic Supplies Glucose Meters/Testing Strips/Pump/Lancets (All Brands/Types) Product Identification Number (PIN) List 999411 Diacomit Capsule 77364987 Diazoxide, USP 72892628 Dibutyl Squarate 77779436 Dichloroacetic Acid 15307796 Diclofenac Sodium Powder, BP 77134805 Diethylpropion HCl,USP (1% Tartaric) 77756531 Diethylstilbestrol, USP 77134623 Diethyltoluamide, USP 77700039 Diffusimax 33286225 Diltiazem Hydrochloride, USP 77700028 Diluent/Vehicle (All Brands, Types and Flavours) Simple Syrup/Ora-Plus 77700271 Dilusol AHA 8% 77700470 Dimenhydrinate, USP 77767710 Dimethyl Sulfone 77767685 Dimethyl Sulfoxide, ACS 77147240 Diphenhydramine Hydrochloride, USP 77732185 Distilled/Purified/Spring Water/Injection/Inhalation/Topical (All Brands/Types) 77797778 Disulfiram, USP 77700040 Doak Oil 71229294 Doxepin Hydrochloride, USP 24390145 Doxycycline Hyclate, USP 17086281 Doxycycline, USP (Monohydrate) 99001382 Durolane 77758866 D-Xylose, BP 77762339 Edetate Calcium Disodium (Anhydrous) 23411349 Edetate Calcium Disodium (Hydrate) 76381926 Edetate Disodium, USP Product Identification Number (PIN) List 77700007 Emulsifying Wax, NF 93106606 Enrofloxacin 77700392 Enuclene 0.25% Ophth 77751434 Epinephrine, USP 71264626 Erythromycin Ethylsuccinate 77643221 Erythromycin Stearate 77114078 Erythromycin, USP Powder 77313064 Estradiol Cypionate, USP 77750282 Estradiol, USP (Micronized) 77750271 Estriol, USP (Micronized) 77753167 Estrone, USP 72624444 Etamsylate, BP 77764175 Ethanol (All Brands/Types) 77760297 Ether 77111900 Ethoxy Diglycol 77775003 Ethyl Chloride (Spray) 77700372 Eye lubrication/Ophthalmic Drops/Gel (All Brands/Types) Lid Care 77700235 Feminine Vaginal (All Brands/Types) Gel/Ovules/Powder/Lady System/Gyne-Moistrin/Replens 77990738 Fentanyl Citrate, USP 71310458 Ferric Subsulfate, USP 77700492 Ferrous sulfate powder 98319267 Finasteride, USP 77700226 Flavouring/FlavoRx Crystal Lyte/Tang/Kool-Aid/Purity Syrup (All Brands/Types/Flavours) 77700008 Flexible Collodion, USP 86386734 Fluconazole, USP 77514363 Fludrocortisone Acetate ,USP (Micr'd) 77767732 Fluocinolone Acetonide, USP Product Identification Number (PIN) List 77700422 Fluorouracil Powder 59333674 Fluoxetine Hydrochloride, USP 77759303 Folic Acid, USP 77750000 Formaldehyde Solution, ACS (37%) 78001909 Friar's Balsam 906794 Fuchsine Powder 60142963 Gabapentin, USP 77700342 Gastro Tubing (All Brands/Types/Sizes) 77700363 Gelatin Capsules 79000708 Gelatin, NF 71405410 Gentamicin Sulfate, USP 77700009 Gentian Violet 1% Topical Solution 77548629 Gentian Violet, USP crystals 77700099 Gloves Cotton/Latex/Vinyl/Latex Free/Sterile (All Brands/Types/Sizes) 38899057 Glucosamine, USP 77111308 Glutaraldehyde Solution (25% Aqueous Solution) 77770188 Glutathione-L (Reduced) 77756815 Glycerin, USP 77756406 Glycine (L) 77779141 Glycolic Acid Crystals 77700010 Glycolic Acid Solution (70%) 77596510 Glycopyrrolate, USP (Powder) 976490 Gonioscopic Prism Solution 77126078 Griseofulvin, USP (Micronized) 77793141 Guaifenesin, USP 77700490 Histofreezer Wart Treatment 77700324 Home Care Accessories (All Products/Brands/Types/Sizes) Product Identification Number (PIN) List 77700494 Humulin R U-500 (Concentrated) - Special Access 77700532 Hyaluronidase 77647010 Hydrochloric Acid 77700172 Hydrocortisone Powder 77750237 Hydrocortisone, USP (Micronized) 77700086 Hydrogen Peroxide (All Brands/Types/Strengths) 77771681 Hydromorphone Hydrochloride, USP 77700013 Hydrophylic Petrolatum, USP 77123319 Hydroquinone, USP Powder 77700043 Hydrous Emollient (eucerin) 13422510 Hydroxocobalamin (Vitamin B12A) 79004620 Hydroxyethyl Cellulose, NF 77127071 Hydroxyurea 77700044 Hypromellose, USP (4000 CPS = 4000 mPa.s) 15687271 Ibuprofen, USP 78029683
Load more

Recommended publications
  • Complementary and Alternative Treatments for Alopecia: a Comprehensive Review
    Review Article Skin Appendage Disord 2019;5:72–89 Received: April 22, 2018 DOI: 10.1159/000492035 Accepted: July 10, 2018 Published online: August 21, 2018 Complementary and Alternative Treatments for Alopecia: A Comprehensive Review Anna-Marie Hosking Margit Juhasz Natasha Atanaskova Mesinkovska Department of Dermatology, University of California, Irvine, Irvine, CA, USA Keywords Introduction Alopecia · Complementary and alternative medicine · Efficacy According to the National Center for Complementary and Integrative Health (NCCIH), a branch of the Nation- al Institutes of Health (NIH; Bethesda, MD, USA), more Abstract than 30% of adults and 12% of children utilize treatments The treatment of alopecia is limited by a lack of therapies developed “outside of mainstream Western, or conven- that induce and sustain disease remission. Given the nega- tional, medicine,” with a total USD 30.2 billion out-of- tive psychosocial impact of hair loss, patients that do not pocket dollars spent annually [1]. In the treatment of alo- see significant hair restoration with conventional therapies pecia, there is an unmet need for therapies providing sat- often turn to complementary and alternative medicine isfying, long-term results. Patients often turn to (CAM). Although there are a variety of CAM treatment op- complementary and alternative medicine (CAM) in an tions on the market for alopecia, only a few are backed by attempt to find safe, natural, and efficacious therapies to multiple randomized controlled trials. Further, these mo- restore hair. Although CAMs boast hair-growing poten- dalities are not regulated by the Food and Drug Administra- tial, patients may be disappointed with results as there is tion and there is a lack of standardization of bioactive in- a lack of standardization of bioactive ingredients and lim- gredients in over-the-counter vitamins, herbs, and supple- ited scientific evidence.
    [Show full text]
  • WO 2014/167554 A2 16 October 2014 (16.10.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/167554 A2 16 October 2014 (16.10.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/10 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/IB20 14/060675 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 12 April 2014 (12.04.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: zw. 1103/DEL/2013 12 April 2013 (12.04.2013) IN (84) Designated States (unless otherwise indicated, for every (71) Applicant: VYOME BIOSCIENCES PVT. LTD. kind of regional protection available): ARIPO (BW, GH, [IN/IN]; 459 F.I.E, First Floor, Patparganj Industrial Area, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, New Delhi 110092 (IN).
    [Show full text]
  • What's the Best Treatment for Cradle Cap?
    From the CLINIcAL InQUiRiES Family Physicians Inquiries Network Ryan C. Sheffield, MD, Paul Crawford, MD What’s the best treatment Eglin Air Force Base Family Medicine Residency, Eglin Air for cradle cap? Force Base, Fla Sarah Towner Wright, MLS University of North Carolina at Chapel Hill Evidence-based answer Ketoconazole (Nizoral) shampoo appears corticosteroids to severe cases because to be a safe and efficacious treatment of possible systemic absorption (SOR: C). for infants with cradle cap (strength of Overnight application of emollients followed recommendation [SOR]: C, consensus, by gentle brushing and washing with usual practice, opinion, disease-oriented baby shampoo helps to remove the scale evidence, and case series). Limit topical associated with cradle cap (SOR: C). ® Dowden Health Media Clinical commentary ICopyrightf parents can’t leave it be, recommend brush to loosen the scale. Although mineral oil andFor a brush personal to loosen scale use noonly evidence supports this, it seems safe Cradle cap is distressing to parents. They and is somewhat effective. want everyone else to see how gorgeous This review makes me feel more FAST TRACK their new baby is, and cradle cap can make comfortable with recommending ketocon- their beautiful little one look scruffy. My azole shampoo when mineral oil proves If parents need standard therapy has been to stress to the insufficient. For resistant cases, a cute hat to do something, parents that it isn’t a problem for the baby. can work wonders. If the parents still want to do something
    [Show full text]
  • Table 1B 2005 Community Prescription Numbers, Together with Government
    TABLE 1B 2005 COMMUNITY PRESCRIPTION NUMBERS, TOGETHER WITH GOVERNMENT AND PATIENT COSTS FOR PBS-LISTED DRUGS Table 1B includes an estimate of community (non-public hospital) prescription numbers for the 2005 calendar year, costs (government and patient contribution) for the items with a four digit PBS/RPBS code, together with the defined daily dose (DDD) where assigned. There is no cost information available for items with a five digit Amfac drug code. Table 1 exclude the presentation of information on any item with an estimated community use of less than 110 prescriptions in 2005. The prescription items are arranged by ATC code on generic name, and by form and strength using either the PBS drug code (4 digit) or, for non-PBS items, the Amfac drug code (5 digit). Consult the index (page 255) by generic drug name to obtain the appropriate ATC code. An index by 2nd level of the ATC classification follows: ALIMENTARY TRACT AND METABOLISM PAGE NO A01 STOMATOLOGICAL PREPARATIONS 181 A02 DRUGS FOR ACID RELATED DISORDERS 182 A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 185 A04 ANTIEMETICS AND ANTINAUSEANTS 187 A05 BILE AND LIVER THERAPY 188 A06 LAXATIVES 189 A07 ANTIDIARRHOEALS, INTESTINAL 191 ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS A08 ANTIOBESITY PREPARATIONS, EXCLUDING DIET PRODUCTS 193 A09 DIGESTIVES, INCLUDING ENZYMES 194 A10 DRUGS USED IN DIABETES 195 A11 VITAMINS 197 A12 MINERAL SUPPLEMENTS 199 A14 ANABOLIC AGENTS FOR SYSTEMIC USE 200 177 BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS 201 B02 ANTIHAEMORRHAGICS 203 B03
    [Show full text]
  • Zinc Therapy in Dermatology: a Review
    Hindawi Publishing Corporation Dermatology Research and Practice Volume 2014, Article ID 709152, 11 pages http://dx.doi.org/10.1155/2014/709152 Review Article Zinc Therapy in Dermatology: A Review Mrinal Gupta, Vikram K. Mahajan, Karaninder S. Mehta, and Pushpinder S. Chauhan DepartmentofDermatology,Venereology&Leprosy,Dr.R.P.Govt.MedicalCollege,Kangra(Tanda),HimachalPradesh176001,India Correspondence should be addressed to Vikram K. Mahajan; [email protected] Received 1 May 2014; Accepted 23 June 2014; Published 10 July 2014 Academic Editor: Craig G. Burkhart Copyright © 2014 Mrinal Gupta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Zinc, both in elemental or in its salt forms, has been used as a therapeutic modality for centuries. Topical preparations like zinc oxide, calamine, or zinc pyrithione have been in use as photoprotecting, soothing agents or as active ingredient of antidandruff shampoos. Its use has expanded manifold over the years for a number of dermatological conditions including infections (leishmaniasis, warts), inflammatory dermatoses (acne vulgaris, rosacea), pigmentary disorders (melasma), and neoplasias (basal cell carcinoma). Although the role of oral zinc is well-established in human zinc deficiency syndromes including acrodermatitis enteropathica, it is only in recent years that importance of zinc as a micronutrient essential for infant
    [Show full text]
  • Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services
    Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services Australian Statistics on Medicines 1997 i © Commonwealth of Australia 1998 ISBN 0 642 36772 8 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be repoduced by any process without written permission from AusInfo. Requests and enquiries concerning reproduction and rights should be directed to the Manager, Legislative Services, AusInfo, GPO Box 1920, Canberra, ACT 2601. Publication approval number 2446 ii FOREWORD The Australian Statistics on Medicines (ASM) is an annual publication produced by the Drug Utilisation Sub-Committee (DUSC) of the Pharmaceutical Benefits Advisory Committee. Comprehensive drug utilisation data are required for a number of purposes including pharmacosurveillance and the targeting and evaluation of quality use of medicines initiatives. It is also needed by regulatory and financing authorities and by the Pharmaceutical Industry. A major aim of the ASM has been to put comprehensive and valid statistics on the Australian use of medicines in the public domain to allow access by all interested parties. Publication of the Australian data facilitates international comparisons of drug utilisation profiles, and encourages international collaboration on drug utilisation research particularly in relation to enhancing the quality use of medicines and health outcomes. The data available in the ASM represent estimates of the aggregate community use (non public hospital) of prescription medicines in Australia. In 1997 the estimated number of prescriptions dispensed through community pharmacies was 179 million prescriptions, a level of increase over 1996 of only 0.4% which was less than the increase in population (1.2%).
    [Show full text]
  • Section 9. Physical and Chemical Properties
    POLYONE CORPORATION SAFETY DATA SHEET AMPVC 325784 Version Number 1.0 Page 1 of 15 Revision Date 05/22/2020 Print Date 05/23/2020 SAFETY DATA SHEET AMPVC 325784 Section 1. Identification GHS product identifier : AMPVC 325784 Chemical name : Mixture CAS number : Mixture Other means of identification : CC10325784 Product type : solid Relevant identified uses of the substance or mixture and uses advised against Product use : Industrial applications. Plastics. Supplier's details : POLYONE CORPORATION 33587 Walker Road, Avon Lake, OH 44012 1 (440) 930-1000 or 1 (866) POLYONE Emergency telephone number : CHEMTREC 1-800-424-9300 (24hrs for spill, leak, fire, exposure or (with hours of operation) accident). Section 2. Hazards identification This mixture has not been evaluated as a whole for health effects. All ingredients are bound in a PVC polymer matrix and potential for hazardous exposure as shipped is minimal. PVC resin is manufactured from Vinyl Chloride Monomer (VCM). PVC resin manufacturers take special efforts to strip residual VCM from their resins. Residual VCM in the resin is typically below 8.5 ppm. However, VCM is a known carcinogen. The end-user (fabricator) should take necessary precautions (mechanical ventilation, local exhaust, respiratory protection, etc.) to protect employees from exposure to any vapors or dusts that may be released during heating or fabrication. See Sections 8 and 11 for special precautions.After handling, always wash hands thoroughly with soap and water. OSHA/HCS status : While this material is not considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200), this SDS contains valuable information critical to the safe handling and proper use of the product.
    [Show full text]
  • Section 2. Hazards Identification
    POLYONE CORPORATION SAFETY DATA SHEET STAN-TONE HCC- AMPVC 184897 Version Number 1.3 Page 1 of 16 Revision Date 08/10/2016 Print Date 08/11/2016 SAFETY DATA SHEET STAN-TONE HCC- AMPVC 184897 Section 1. Identification GHS product identifier : STAN-TONE HCC- AMPVC 184897 Chemical name : Mixture CAS number : Mixture Other means of identification : FO20031738 Product type : liquid Relevant identified uses of the substance or mixture and uses advised against Product use : Industrial applications. Plastics. Supplier's details : POLYONE CORPORATION 1675 Navarre Road SW, Massillon, Ohio USA 44646 1 330 837 8679 Emergency telephone number : CHEMTREC 1-800-424-9300 (24hrs for spill, leak, fire, exposure or (with hours of operation) accident). Section 2. Hazards identification This mixture has not been evaluated as a whole. Information provided on the health effects of this product is based on individual components. Some vapors may be released upon heating and the end-user (fabricator) must take the necessary precautions (mechanical ventilation, respiratory protection, etc.) to protect employees from exposure.After handling, always wash hands thoroughly with soap and water. OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Classification of the substance or : ACUTE TOXICITY (oral) - Category 4 mixture ACUTE TOXICITY (dermal) - Category 4 ACUTE TOXICITY (inhalation) - Category 4 SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2B GHS label elements 1/16 POLYONE CORPORATION SAFETY DATA SHEET STAN-TONE HCC- AMPVC 184897 Version Number 1.3 Page 2 of 16 Revision Date 08/10/2016 Print Date 08/11/2016 Hazard pictograms : Signal word : Warning Hazard statements : Harmful if swallowed, in contact with skin or if inhaled.
    [Show full text]
  • Dermatology Medication Monitoring
    VA SAN DIEGO HEALTHCARE SYSTEM DERMATOLOGY DRUG FORMULARY RESTRICTED DRUGS IN ITALIC MEDICATION MONITORING IN *ASTERISK * ACNE PRODUCTS (topical) ANTI-FUNGAL (topical) SCABICIDES/PEDICULOCIDES Erythromycin 2% solution (60ml) Clotrimazole 1% cream (15g) Permethrin 1% liquid (60ml), 5% cream (60g) 1 2 Clindamycin 1% swab (#60) Ketoconazole 2% cream (30g), shampoo (120ml) Ivermectin 3mg tabs Benzoyl Peroxide 2.5%, 5%, 10% gel (60g) Metronidazole 0.75% cream (45g) EMOLLIENTS/KERATOLYTICS 5% lotion (30g) Miconazole 2% cream (30g), tincture (30ml) Ammonium lactate 12% lotion (225ml) Tretinoin 0.025%, 0.05%, 0.1% (60g) Nystatin Powder (30g) Petrolatum oint (30, 454g) Podofilox 0.5% soln (3.5ml) ACNE PRODUCTS (oral) Urea 10% lotion (240ml) Terbinafine 1% cream (30g) Doxycycline 50, 100 mg caps 10%, 20% cream (90g) Minocycline 50, 100 mg caps ANTI-PSORIATICS (topical) Salicylic acid 3% shampoo (120ml) *Isotretinoin* 10, 20, 30, 40 mg caps Coal tar Emulsion 7.5% (180ml) 40% plaster (#1) Shampoo 0.5% (255ml), 1% (180ml) Salicylic acid/Sulfur 2%/2% shampoo (120ml) ANTI-INFECTIVES (topical) Calcipotriene 0.005% cream (60g) Bacitracin 500 U (30g) TOPICAL ANESTHETICS 3 Bacitracin/polymyxin 500/10000 U/gm (30g) ANTI-PSORIATICS (oral) Capsaicin 0.025%, 0.1% cream (60g) Clindamycin phosphate 1% swab (#60) Acitretin 10, 25 mg caps Dibucaine 1% oint (30g) Mupirocin 2% oint (22g) *Azathioprine* 50 mg tabs Lidocaine 4% cream (30g), 5% oint (35g) Silver sulfadiazine 1% cream (50, 85, 400g) *Methotrexate* 2.5 mg tabs Lidocaine/Prilocaine 2.5%/2.5% cream(30g)
    [Show full text]
  • Evidence-Based Danish Guidelines for the Treatment of Malassezia- Related Skin Diseases
    Acta Derm Venereol 2015; 95: 12–19 SPECIAL REPORT Evidence-based Danish Guidelines for the Treatment of Malassezia- related Skin Diseases Marianne HALD1, Maiken C. ARENDRUP2, Else L. SVEJGAARD1, Rune LINDSKOV3, Erik K. FOGED4 and Ditte Marie L. SAUNTE5; On behalf of the Danish Society of Dermatology 1Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, 2 Unit for Mycology, Statens Serum Institut, 3The Dermatology Clinic, Copen- hagen, 4The Dermatology Clinic, Holstebro, and 5Department of Dermatology, Roskilde Hospital, University of Copenhagen, Denmark Internationally approved guidelines for the diagnosis including those involving Malassezia (2), guidelines and management of Malassezia-related skin diseases concerning the far more common skin diseases are are lacking. Therefore, a panel of experts consisting of lacking. Therefore, a panel of experts consisting of dermatologists and a microbiologist under the auspi- dermatologists and a microbiologist appointed by the ces of the Danish Society of Dermatology undertook a Danish Society of Dermatology undertook a data review data review and compiled guidelines for the diagnostic and compiled guidelines on the diagnostic procedures procedures and management of pityriasis versicolor, se- and management of Malassezia-related skin diseases. borrhoeic dermatitis and Malassezia folliculitis. Main The ’head and neck dermatitis’, in which hypersensi- recommendations in most cases of pityriasis versicolor tivity to Malassezia is considered to be of pathogenic and seborrhoeic dermatitis include topical treatment importance, is not included in this review as it is restric- which has been shown to be sufficient. As first choice, ted to a small group of patients with atopic dermatitis. treatment should be based on topical antifungal medica- tion.
    [Show full text]
  • Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
    Updated June 07, 2021 Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Three categories of bulk drug substances: • Category 1: Bulk Drug Substances Under Evaluation • Category 2: Bulk Drug Substances that Raise Significant Safety Risks • Category 3: Bulk Drug Substances Nominated Without Adequate Support Updates to Categories of Substances Nominated for the 503B Bulk Drug Substances List1 • Add the following entry to category 2 due to serious safety concerns of mutagenicity, cytotoxicity, and possible carcinogenicity when quinacrine hydrochloride is used for intrauterine administration for non- surgical female sterilization: 2,3 o Quinacrine Hydrochloride for intrauterine administration • Revision to category 1 for clarity: o Modify the entry for “Quinacrine Hydrochloride” to “Quinacrine Hydrochloride (except for intrauterine administration).” • Revision to category 1 to correct a substance name error: o Correct the error in the substance name “DHEA (dehydroepiandosterone)” to “DHEA (dehydroepiandrosterone).” 1 For the purposes of the substance names in the categories, hydrated forms of the substance are included in the scope of the substance name. 2 Quinacrine HCl was previously reviewed in 2016 as part of FDA’s consideration of this bulk drug substance for inclusion on the 503A Bulks List. As part of this review, the Division of Bone, Reproductive and Urologic Products (DBRUP), now the Division of Urology, Obstetrics and Gynecology (DUOG), evaluated the nomination of quinacrine for intrauterine administration for non-surgical female sterilization and recommended that quinacrine should not be included on the 503A Bulks List for this use. This recommendation was based on the lack of information on efficacy comparable to other available methods of female sterilization and serious safety concerns of mutagenicity, cytotoxicity and possible carcinogenicity in use of quinacrine for this indication and route of administration.
    [Show full text]
  • LIST of REGISTRED OTC DRUGS in ARMENIA (Up to 31.03.2017)
    LIST OF REGISTRED OTC DRUGS IN ARMENIA (Up to 31.03.2017) International nonproprietary Registration Term of Legal status for N Trade name name (generic) or Drug form Dose and packaging Manufacturer Country ATC1 code License holder number registration supply active ingredients name Help S.A ,10 ambroxol Help S.A. Pedini, Valaoritou str., GR 6mg/ml, 09.03.2016 1 Abrobion (ambroxol syrup Ioanninon, Ioannina, Greece R05CB06 15404 OTC 144 52, 125ml glass bottle 09.03.2021 hydrochloride) 45500 Metamorphosis, Attika, Greece Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 100mg/5ml, 39179 Barleben-batch Sandoz 30g powder in 75ml glass powder for oral releaser, Allphamed Pharmaceuticals d.d., bottle and measuring 20.10.2015 2 ACC acetylcysteine solution with orange Pharbil Arzneimittel Germany R05CB01 14947 OTC Verovskova Str. 57, spoon 5ml, 60g powder in 20.10.2020 flavour GmbH Hildebrandstr. 1000 Ljubljana, 150ml glass bottle and 12, 37081 Gottingen, Slovenia measuring spoon 5ml Germany-bulk manufacturer, packager Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 39179 Barleben - Sandoz batch releaser Pharmaceuticals d.d., 100mg, 21.11.2014 3 ACC 100 acetylcysteine tablets effervescent (Hermes Pharma Germany R05CB01 13967 OTC Verovskova Str. 57, in plastic container (20) 21.11.2019 G.m.b.H., Allgau 36, 1526 Ljubljana, A-9400 Wolsberg, Slovenia Germany - bulk manufacturer, packager) 1 Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, Sandoz 39179 Barleben-batch Pharmaceuticals d.d., powder for oral 100mg, releaser, Lindopharm 14.04.2015 4 ACC 100 acetylcysteine Germany R05CB01 14430 OTC Verovskova Str. 57, solution 3g sachets (20) GmbH, Neustrasse 82, 14.04.2020 1000 Ljubljana, D-40721 Hilden, Slovenia Germany- bulk manufacturer, packager Salutas Pharma GmbH, Otto-von- Guericke-Alle-1, 39179 Barleben - Sandoz batch releaser Pharmaceuticals d.d., 200mg, 21.11.2014 5 ACC 200 acetylcysteine tablets effervescent (Hermes Pharma Germany R05CB01 13968 OTC Verovskova Str.
    [Show full text]